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ADVANCING EARLY DETECTION
A HEALTHY BRAIN INITIATIVE ISSUE MAP
 » Nearly 90% of Americans say that if they were 
exhibiting confusion and memory loss, they would 
want to know if the cause of the symptoms was 
Alzheimer’s disease. Yet, over half of the people aged 
45 and older with subjective cognitive decline have not 
talked with a healthcare provider about their questions, 
concerns, and fears. Among those whose memory 
problems were creating functional difficulties, 42% had 
not shared these issues with a provider.7  
 » Evidence indicates that less than half of people with 
dementia have been diagnosed by a physician. Among 
older adults who have been diagnosed with dementia, 
only 35% are aware that they have the disease.3 
 » Missed diagnoses of dementia are more common 
among African Americans than whites. While 
African Americans are two times more likely to have 
Alzheimer’s or another dementia than whites, they are 
only 36% more likely to receive a diagnosis.8  Also, 
both African Americans and Hispanics with cognitive 
impairment are less likely than whites to say that a 
doctor has told them they have a “memory-related 
disease.”9
 » Physicians face barriers regarding diagnosis, 
evidenced by the low rate of documentation of 
cognitive decline in medical records. Less than half of 
those with Alzheimer’s and other dementias have their 
diagnoses documented in their medical records.10,11
 » Economic modeling shows that early diagnosis can 
greatly reduce healthcare costs across the nation, 
particularly through reduced hospitalizations and better 
management of chronic conditions—potentially up to 
$64,000 per person with dementia.12 
COMPELLING DATAThe earlier that Alzheimer’s and other dementias are 
diagnosed, the sooner people and their families can 
receive information, care, and support. As the compelling 
data indicate, many Americans are not being diagnosed 
early or told about their diagnosis.
The symptoms of Alzheimer’s and other dementias 
worsen over time, although the rate at which the disease 
progresses varies. In the early stage of Alzheimer’s 
dementia, for example, a person may function 
independently, still drive, work, and be part of social 
activities. Despite this, the person may notice memory 
lapses, such as forgetting familiar words or the location of 
everyday objects. 
A formal diagnosis allows people living with dementia to 
have access to available symptomatic treatments and 
interventions, build a care team, participate in support 
services, and potentially enroll in clinical trials. They 
and their caregivers can set systems in place to better 
manage medications, receive counseling, and address the 
challenges of other chronic conditions. 
Additional advantages include planning for future 
financial and legal needs and end of life choices. 
Public health can impact early detection and diagnosis 
by developing professional competencies needed to 
effectively and compassionately interact with and assess 
people with cognitive impairment and their caregivers. 
For timely and accurate early detection to occur — and 
subsequent diagnosis and disclosure awareness — people 
must feel comfortable discussing symptoms and concerns 
with their healthcare providers. This requires addressing 
barriers such as low public awareness of the early signs 
of Alzheimer’s, emotional distress of Alzheimer’s and 
other dementias on family members, and misperceptions 
about Alzheimer’s and other dementias.1,2  In addition, 
public health should consider addressing obstacles 
faced by physicians such as: low recognition of the signs 
of cognitive impairment; confusion with conditions that 
may mimic dementia (including delirium, certain vitamin 
deficiencies, and depression); limited education or 
training on dementia care; concerns about stigma and the 
usefulness of an early diagnosis; lack of time; and difficulty 
talking about dementia or disclosing a diagnosis.3,4,5,6  
ADVANCING EARLY DETECTION to Make Alzheimer’s Our 
Next Public Health Success Story
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EDUCATE & EMPOWER
E-1    Educate the public about brain health and cognitive 
aging, changes that should be discussed with a health 
professional, and benefits of early detection and diagnosis.
E-5   Provide information and tools to help people with 
dementia and caregivers anticipate, avert, and respond 
to challenges that typically arise during the course of 
dementia.
E-6   Strengthen knowledge about, and greater use of, 
care planning and related tools for people with all stages of 
dementia.
DEVELOP POLICIES & MOBILIZE 
PARTNERSHIPS
P-1 Promote the use of effective interventions and 
best practices to protect brain health, address cognitive 
impairment, and help meet the needs of caregivers for 
people with dementia.
P-4 Improve inclusion of healthcare quality measures 
that address cognitive assessments, the delivery of care 
planning to people with diagnosed dementia, and improved 
outcomes. 
P-6 Assure public health plans that guide emergency 
preparedness and emergency response address the 
special needs of people with dementia and their caregivers, 
support access to critical health information during crises, 
and prepare emergency professionals for situations 
involving people with dementia.
ASSURE A COMPETENT  
WORKFORCE 
W-3 Educate public health professionals about the best 
available evidence on dementia (including detection) and 
dementia caregiving, the role of public health, and sources 
of information, tools, and assistance to support public 
health action.
W-4 Foster continuing education to improve healthcare 
professionals’ ability and willingness to support early 
diagnoses and disclosure of dementia, provide effective 
care planning at all stages of dementia, offer counseling 
and referral, and engage caregivers, as appropriate, in 
care management. 
W-5 Strengthen the competencies of professionals 
who deliver healthcare and other care services to people 
with dementia through interprofessional training and other 
strategies.
W-6 Educate healthcare professionals about the 
importance of treating co-morbidities, addressing injury 
risks, and attending to behavioral health needs among 
people at all stages of dementia.
MONITOR & EVALUATE
 
M-2 Support national data collection on dementia and 
caregiving.  
M-3 Use data gleaned through available surveillance 
strategies and other sources to inform the public health 
program and policy response to cognitive health, 
impairment, and caregiving.  
M-5 Estimate the gap between workforce capacity and 
anticipated demand for services to support people with 
dementia and their caregivers.
THE EARLY DETECTION ACTION AGENDA
The Healthy Brain Initiative’s (HBI) State and Local Public Health Partnerships to Address Dementia, The 2018–2023 
Road Map charts a course for state and local public health agencies and their partners to act quickly and strategically 
to prepare all communities by stimulating changes in policies, systems, and environments. Many of the Road Map’s 25 
expert-developed actions would advance early detection and diagnosis of Alzheimer’s and other dementias.
For the full HBI Road Map, data, ready-to-
use resources, and case studies, visit: 
alz.org/publichealth or cdc.gov/aging.
WASHINGTON
Washington Department 
of Health (DOH) partnered 
with the Seattle-based, 
nonprofit Center for 
MultiCultural Health 
(CMCH) to help tailor and 
disseminate brain health 
messages to African 
American audiences. CMCH 
identified African American churches as a promising venue 
to reach women and recommended creating hand fans 
printed with culturally-tailored messages. 
Additionally, the National Asian Pacific Center on Aging 
(NAPCA) and the University of Washington Healthy Brain 
Research Network (UW-HBRN) partnered to conduct 
outreach and education for Seattle Asian Americans and 
Pacific Islanders (AAPIs). Following six focus groups of 
local Chinese and Japanese adults with at least one living 
relative aged 65 or over, they released two briefs on their 
findings: Connecting with AAPIs about Dementia: An 
Action Guide for Service Providers and Connecting with 
AAPIs about Dementia: An Action Guide for Policymakers. 
The importance of early detection of cognitive impairment 
is emphasized in the guide for service providers. 
UTAH
Utah Department of Health 
(UDOH) contracted with 
HealthInsight, a quality 
improvement organization, to 
interview providers about their 
experiences and processes 
conducting cognitive assessments 
during the Medicare Annual 
Wellness Visit (AWV). The study 
revealed that 57% of the 16 physicians interviewed use 
the Mini-Mental Status Exam, a validated tool to assess 
cognition during the AWV. Providers expressed a need 
for better tools to detect early-stage memory loss. The 
resulting report, Cognitive Assessments during Medicare 
Annual Wellness Visits, deepened UDOH’s understanding 
of challenges that physicians face in assessing cognition 
during the AWV, one of which was uncertainty about which 
validated tool to use. 
With some legislative support, UDOH continues to 
collaborate with HealthInsight to develop: cognitive 
assessment training for primary care physicians and their 
office staff on use of recommended tools and workflow 
improvement techniques and also a cognitive health and 
wellness toolkit to help health professionals navigate the 
cognitive assessment process, including assessment, 
diagnosis, referrals, and community resources.
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PUBLIC HEALTH STRATEGIES TO ADVANCE EARLY 
DETECTION
The full HBI Road Map, other examples of 
strategies used by state public health agencies, 
and additional resources are available at               
alz.org/publichealth and cdc.gov/aging.
Data to guide your efforts can be found on your 
state’s portal at alz.org/publichealth and at the 
Centers for Disease Control and Prevention’s 
Healthy Aging Data Portal at cdc.gov/aging.
The following are examples of how public health departments are advancing early detection.
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